Archive

2026-07-22 09:30 • The Motley Fool Positive Axe Cap view: Selective CRSP ARKK ARKG NVS BMY CELGR GILD

Cathie Wood's Ark Investment Management holds $362 million in CRISPR Therapeutics across two ETFs. While known for gene-editing work like the FDA-approved Casgevy, the company is quietly developing CAR T-cell therapies that could address a market projected to exceed $60 billion annually by 2034. CRISPR's off-the-shelf CAR T approach using donor cells could reduce costs compared to patient-specific treatments, positioning it competitively despite being in early trial stages.

Axe note: Ark’s sizable investment in CRISPR Therapeutics highlights a gene therapy play that could grow faster than many expect, even from South Africa.

2026-07-22 09:06 • The Motley Fool Negative Axe Cap view: Bearish IONQ IONQ.WS RGTI RGTIW QBTS

Despite massive gains in quantum computing stocks IonQ, Rigetti, and D-Wave since mid-2024, insiders at these companies have collectively sold over $988 million in stock over the past five years with minimal insider buying. The article warns that extreme valuations (P/S ratios of 60-459) and lack of insider confidence suggest caution, as broad-based adoption remains years away and historical tech bubbles typically precede major corrections.

Axe note: Quantum computing stocks are surging, but heavy insider sales warn of a bubble about to burst.

2026-07-22 09:05 • The Motley Fool Positive Axe Cap view: Selective KO BRK.A BRK.B AXP KHC

Berkshire Hathaway's 38-year investment in Coca-Cola continues to be exceptionally lucrative, generating $816 million in annual dividends on a $1.299 billion cost basis. With a 2.6% dividend yield and 65 consecutive years of dividend increases, the investment returns over 60% of its original cost annually, making it an easy hold for new CEO Greg Abel.

Axe note: Berkshire Hathaway’s decades-long Coca-Cola stake highlights the power of steady dividend growth, a lesson for JSE investors.

2026-07-22 08:31 • The Motley Fool Positive Axe Cap view: Selective AMJB JPM JPMPC JPMPD JPMPJ JPMPK JPMPL JPMPM VYLD SCBFY

The crypto industry has spent $189 million lobbying for the Clarity Act, which would grant the CFTC exclusive jurisdiction over digital asset spot markets and codify Bitcoin, Ethereum, and XRP as commodities. However, prediction markets give the bill only a 31% chance of passing by year-end due to Democratic demands for ethics language and unresolved stablecoin yield questions. XRP has the most to gain from passage, while Bitcoin has the least.

Axe note: The crypto industry’s $189 million push for US regulatory clarity signals opportunities, but South African investors should remain cautious.

2026-07-22 08:15 • The Motley Fool Positive Axe Cap view: Bullish O WMT FDX WYNN

Realty Income (O) is presented as an attractive long-term dividend investment with a wide competitive moat. The REIT owns nearly 15,600 single-tenant, net-leased properties rented to major companies like Walmart and FedEx. It offers a 4.9% dividend yield with consistent monthly payouts and annual increases since 1994. Despite rising interest rates dampening stock price growth, the company has successfully expanded its portfolio through acquisitions, suggesting strong fundamentals and potential for future stock price recovery.

Axe note: A blue-chip REIT with steady income and growing property portfolio deserves a closer look from dividend hunters.

2026-07-22 08:06 • The Motley Fool Negative Axe Cap view: Selective ONEQ

Cleveland Federal Reserve President Beth Hammack has signaled that broad-based inflation remains a significant concern for the Fed, with Core PCE projections at 3.3%. She notes that businesses and consumers are expressing growing concerns about inflation's persistence. This hawkish stance suggests potential rate hikes ahead, which could negatively impact the highly valued stock market, particularly AI-related investments that rely on cheap debt financing for data center expansion.

Axe note: Cleveland Fed’s Beth Hammack signals stubborn inflation and looming rate hikes, putting pressure on growth stocks and riskier assets.

2026-07-22 08:02 • The Motley Fool Mixed Axe Cap view: Selective AAPL NVDA GOOG GOOGL GOOGM GOOGN TSM ARM

Apple recently reclaimed the title of world's largest company but faces valuation concerns with a forward P/E of 34x and risks from higher device prices impacting upgrade cycles. Nvidia, trading at a cheaper 16x forward P/E, offers better growth prospects with its dominant AI infrastructure position, expanding networking portfolio, and strong positioning in the emerging inference market. The analyst recommends Nvidia as the more attractive megacap tech stock despite risks from eventual AI infrastructure spending slowdown.

Axe note: Nvidia offers more attractive growth and valuation than Apple despite both being tech giants.

2026-07-22 07:12 • The Motley Fool Positive Axe Cap view: Selective META NBIS HUT IREN

Meta Platforms is reportedly in early-stage talks with Anthropic for a $10 billion compute lease deal over 2 years, raising concerns among neocloud investors about potential competition. However, Meta's own massive compute needs and the strong demand from AI developers suggest neoclouds like Nebius, CoreWeave, and Iren can diversify their customer bases and secure long-term contracts ahead of potential hyperscaler competition.

Axe note: Meta's potential $10 billion compute lease deal with Anthropic sparks debate on neocloud competitiveness.

2026-07-22 06:12 • The Motley Fool Positive Axe Cap view: Selective MU WDC SNDK

Memory chip stocks surged on Tuesday following a Morgan Stanley forecast predicting memory prices will rise at least 25% from Q2 to Q3, driven by AI data-center demand. Micron rose 12.26%, Western Digital 12.60%, and Sandisk 14.27%, reversing recent declines as investors regained confidence in the memory boom's continuation.

Axe note: Memory chip stocks jump on AI demand, with implications for the rand and select JSE sectors.

2026-07-22 05:22 • The Motley Fool Negative Axe Cap view: Selective APP META AAPL

AppLovin stock declined 24% in the first half of 2026 despite strong financial performance, driven by concerns about AI disruption, competition from Meta in iOS ad tracking, and a short-seller attack. However, the company continues to deliver impressive revenue growth (66% increase) and profit margins, with management showing confidence through stock buybacks.

Axe note: AppLovin's share slump despite strong growth signals pressure from AI and Meta that South African tech investors should watch.

2026-07-22 03:23 • The Motley Fool Neutral Axe Cap view: Selective SPCX

SpaceX faces a massive short position of 206 million shares (32% of tradable float) worth $25 billion. CEO Elon Musk claims short sellers have "very low" survival probability, but the stock has fallen 45% from its post-IPO peak to $123.46. While a potential short squeeze could occur before the company's first earnings report on Aug. 4, expanding lock-up expirations will increase share supply, potentially easing short pressure. The stock trades at 80+ times sales despite impressive 33% revenue growth, leaving valuation concerns unresolved.

Axe note: SpaceX’s heavy short interest and lofty valuation signal caution, with a potential short squeeze adding volatility ahead of earnings.

2026-07-22 03:05 • The Motley Fool Positive Axe Cap view: Selective AMD MSFT NVDA

AMD stock surged 7.91% after expanding its partnership with Microsoft to deploy Helios rack-scale systems on Azure cloud computing for AI inference workloads. The integrated system combines AMD's Instinct GPUs, Venice CPUs, and networking solutions to reduce AI application costs. Despite Nvidia's dominance with over 90% market share in data center AI chips, AMD's cost-efficient approach could help it gain market share in the rapidly expanding AI market.

Axe note: AMD’s new deal with Microsoft rattles Nvidia’s dominance and hints at cost savings that could ripple to FX markets and local tech sentiment.

2026-07-22 02:15 • The Motley Fool Neutral Axe Cap view: Selective AFL

Aflac has maintained a 43-year streak of dividend increases, with the latest hike at 5.2%. However, investors should be aware that the company derives over two-thirds of its pre-tax earnings from Japan, making it heavily exposed to currency fluctuations between the U.S. dollar and Japanese yen. While the company has managed this risk well historically through aggressive stock buybacks, currency movements could materially impact financial results.

Axe note: Aflac’s long dividend streak comes with a currency risk twist that South African investors should note.

2026-07-22 00:18 • The Motley Fool Positive Axe Cap view: Selective SYNA

Synaptics' Chief Strategy Officer Satish Ganesan sold 1,465 shares for tax withholding purposes, retaining 61,834 shares worth $7.1 million. The transaction signals confidence in the company's strategic pivot toward IoT and edge computing, where Core IoT sales jumped 31% last quarter with full-year IoT revenue expected to exceed $385 million, while legacy mobile touch business declines.

Axe note: Synaptics’ pivot to IoT is accelerating, backed by strong insider conviction and solid sales growth.

2026-07-22 00:05 • The Motley Fool Negative Axe Cap view: Selective SPCX

SpaceX stock has declined below its $135 IPO price to around $119, but analyst Adria Cimino remains cautious about buying despite the pullback. While the company shows promise with its integrated rocket, connectivity, and AI businesses, concerns include high valuation relative to risk, limited visibility, and capital expenditures ($20B) exceeding revenue ($18B). Morningstar's fair value estimate of $63 suggests the stock remains overpriced.

Axe note: Despite a 20% drop, SpaceX’s valuation and spending keep it off my buy list for now.

2026-07-21 23:30 • The Motley Fool Positive Axe Cap view: Selective NFLX

Despite Netflix shares being down 45% over the past 12 months due to slowing revenue growth and competition concerns, the article argues there are strong reasons for optimism. Netflix has penetrated only 45% of addressable households and captures just 7% of addressable revenue market, indicating massive growth potential. The company is expanding live programming (including sports rights like the FIFA Women's World Cup and plans to bid for the Men's World Cup), long-form video podcasts, and gaming initiatives to boost subscriber engagement and leverage its strong brand moat.

Axe note: Netflix's low market penetration and new content push offer growth, but South African investors should weigh FX and local relevance.

2026-07-21 23:30 • The Motley Fool Positive Axe Cap view: Selective BRK.A BRK.B GOOG GOOGL GOOGM GOOGN AAPL AMZN

Warren Buffett disclosed that he personally initiated Berkshire Hathaway's investment in Alphabet, surprising many who expected the move to come from incoming CEO Greg Abel. The investment underscores how large tech companies like Alphabet have become accessible to traditional value investors due to their understandable business models centered on familiar products like Google Search and YouTube.

Axe note: Warren Buffett’s personal push to invest Berkshire Hathaway’s capital in Alphabet underscores a new respect for big tech's sturdy business models.

2026-07-21 23:03 • The Motley Fool Positive Axe Cap view: Selective NBIS NVDA MSFT META

Nebius Group stock surged 18.91% after Nvidia disclosed a 9.3% equity stake (22.3 million shares) worth approximately $5 billion. The investment follows a strategic partnership announced in March between the two companies to deploy AI-focused cloud computing infrastructure. Nebius has secured over $40 billion in contracted revenue from major tech partners including Microsoft and Meta.

Axe note: Nvidia’s $5 billion equity stake in Nebius highlights the growing AI cloud infrastructure race.

2026-07-21 22:30 • The Motley Fool Positive Axe Cap view: Selective ABBV ABT APGE

AbbVie has demonstrated strong recovery after Humira's patent loss, with immunology drugs Skyrizi and Rinvoq exceeding sales expectations and not facing biosimilar competition until 2033. The company maintains a promising pipeline including weight-loss therapy ABBV-295 and acquired eczema treatment zumilokibart. AbbVie's Dividend King status with 203.5% dividend increases over the past decade and a 2.7% yield makes it an attractive long-term investment despite near-term headwinds from Humira decline and Imbruvica pricing pressure.

Axe note: AbbVie’s post-Humira bounce looks strong, but South African investors should be cautious given local market dynamics.

2026-07-21 22:26 • The Motley Fool Positive Axe Cap view: Selective REET HAUZ

The iShares Global REIT ETF (REET) and Xtrackers International Real Estate ETF (HAUZ) offer different approaches to real estate investing. REET includes U.S. exposure and delivered 19% returns over one year, while HAUZ focuses on international markets with a lower expense ratio (0.10% vs 0.14%) and higher dividend yield (3.57% vs 3.26%). REET has outperformed over both one- and five-year periods despite HAUZ's cost advantages, with both funds benefiting from stabilizing interest rates.

Axe note: REET’s broader U.S. exposure and size currently make it a stronger play than HAUZ in global real estate ETFs.